|RDY -- USA Stock|| |
USD 37.41 0.07 0.19%
Dr Reddys ebitda fundamental analysis lookup allows you to check this and other indicators for Dr Reddys Laboratories Ltd or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners
to view more equity screening tools
Dr Reddys EBITDA Analysis
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Dr Reddys ValuationFundamentalsBuy or Sell
|Dr Reddys ||EBITDA|| = |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
According to company disclosure Dr Reddys Laboratories Ltd reported earnings before interest,tax, depreciation and amortization of 429.93 M
. This is 51.0% lower than that of the Healthcare sector, and 26.98% lower than that of Drug Manufacturers - Specialty & Generic
industry, The EBITDA for all stocks is 88.97% higher than the company.
Screen CEOs from public companies around the world
Dr Reddys current financial ratios